Neurocognitive Adverse Events in Patients With ALK or ROS1-Positive, Advanced or Metastatic NSCLC Receiving Lorlatinib.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer（2023）
关键词
neurocognitive adverse events,metastatic nsclc,lorlatinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要